Induction of cisplatinum sensitivity without alteration in radiation sensitivity by fractionated radiation treatment of a human laryngeal squamous cell carcinoma cell line
- 1 June 1995
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 32 (3) , 681-685
- https://doi.org/10.1016/0360-3016(94)00634-w
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Expression off resistance to etoposide and vincristine in vitro and in vivo after X-irradiation of ovarian tumor cellsAnti-Cancer Drugs, 1992
- Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitroCarcinogenesis: Integrative Cancer Research, 1992
- Interactions between antitumour agents and radiation and the expression of resistanceCancer Treatment Reviews, 1991
- Enhanced dna repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Overexpression of P-glycoprotein in Mammalian Tumor Cell Lines After Fractionated X Irradiation In VitroJNCI Journal of the National Cancer Institute, 1990
- Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre‐exposed in vitro to either X‐irradiation or cisplatinInternational Journal of Cancer, 1987
- Effects of Fractionated X-irradiation on Subsequent Response to Acute X-irradiation in Two Human Tumour Cell Linesin VitroInternational Journal of Radiation Biology, 1987
- Biological basis for the interaction of chemotherapeutic agents and radiation therapyCancer, 1985
- Establishment of an etoposide‐resistant human epithelial tumour cell line In vitro: Characterization of patterns of cross‐resistance and drug sensitivitiesInternational Journal of Cancer, 1984
- Drug or radiation changes to the host which could affect the outcome of combined modality therapyInternational Journal of Radiation Oncology*Biology*Physics, 1979